Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Prothena reported $58.49M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 172.05M 10.51M
Agios Pharmaceuticals AGIO:US USD 96.22M 120.59M
Akebia Therapeutics AKBA:US USD 65.06M 3.53M
Alnylam Pharmaceuticals ALNY:US USD 469.1M 54.55M
Amgen AMGN:US USD 4.07B 538M
Biogen BIIB:US USD 1.96B 111.2M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Bluebird Bio BLUE:US USD -6056000 19.32M
Exelixis EXEL:US USD 379.96M 92.04M
Immunic Inc. VTL:US USD 27.25M 30.08M
Incyte Corp INCY:US USD 783.9M 72.7M
Intercept Pharmaceuticals ICPT:US USD 99.59M 4.35M
Intra Cellular Therapies ITCI:US USD 143.7M 8.42M
Ionis Pharmaceuticals IONS:US USD 244.67M 115.24M
MacroGenics MGNX:US USD 62.92M 1.81M
Nektar Therapeutics NKTR:US USD 156.3M 81.81M
Neurocrine Biosciences NBIX:US USD 534.6M 226M
Prothena PRTA:US USD 58.49M 8.5M
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Seattle Genetics SGEN:US USD 704.23M 22.08M
Ultragenyx Pharmaceutical RARE:US USD 254.6M 5.62M
Vertex Pharmaceuticals VRTX:US USD 1.6B 326.6M
Xoma XOMA:US USD 10.61M 2.91M